Immunis Funding & Investors
Immunis a private biotechnology company developing a novel treatment for age and disease-related immune decline.
immunisbiomedical.comTotal Amount Raised: $25,793,916
Immunis Funding Rounds
Series Unknown
$15,793,916
Series A
$10,000,000
Series A Investors
Remiges VenturesContinuum Health Ventures
Funding info provided by Diffbot.